Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Atosiban

1

II.a Pulmonary edema, noncardiogenic (NCPE)

1
Last update : 20/01/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Atosiban-induced acute pulmonary edema: A rare but severe complication of tocolysis.
Heliyon 2023 May;9;e15829 2023 May
A case of severe non-cardiogenic pulmonary edema in a woman treated with atosiban for preterm labor.
European review for medical and pharmacological sciences 2023 Feb;27;1305-1310 2023 Feb
The combination of corticosteroid and tocolytic therapy in a preeclamptic patient is a risk factor for the development of acute pulmonary oedema.
International journal of obstetric anesthesia 2018 May;34;113-114 2018 May
Non-cardiogenic pulmonary edema in a woman treated with atosiban for preterm labor.
European journal of obstetrics, gynecology, and reproductive biology 2017 Dec;219;132-133 2017 Dec
Severe non-cardiogenic pulmonary oedema secondary to atosiban and steroids.
International journal of obstetric anesthesia 2011 Apr;20;189-90 2011 Apr
Non-cardiogenic lung edema in a woman treated with atosiban for preterm labor.
Journal of perinatal medicine 2008;36;455-7 2008

Powered by

  • ^
  • Contact
  • Cookies
  • About